Skip to main content

RT @synovialjoints: Getting closer to personalised medicine in AS, ECM-mediated biomarkers may help predict response to

Social Author Name
Dr. Antoni Chan
Tweet Content
Getting closer to personalised medicine in AS, ECM-mediated biomarkers may help predict response to Adalimumab in AS. The biomarkers C1M, C6M and PRO-C4 were lower in responders to adalimumab treatment after 24 weeks @RheumNow #ACR21 Abst#0915 https://t.co/K2YxPvUAwu https://t.co/w9kcBSFeG9
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×